Make your money go further for just 25p per day

PREMIUM
AIM IHT

Trading ahead | Positive cash flow | Manufacturing issues

09/04/2024 · Animalcare (ANCR)  · Cake Box (CBOX)  · Impax Asset Management (IPX)  · Intercede Group (IGP)  · Microlise (SAAS)  · Surface Transforms (SCE)  · Warpaint London (W7L) 

AIM AIM Inheritance Tax potential Dividends UK

Image illustrating brake discs, fresh cream cakes and cosmetics

News covered here includes our assessment of another disappointing update from one niche manufacturer which is struggling to ramp-up its manufacturing and convert a sizeable order book. Elsewhere, there was more positive news from the world of software, cosmetics and fresh cream cakes - we know which one of those we prefer! Read on here for our latest forthright opinion on this and other news. (Premium)


Intercede: still doing well

Intercede (AIM:IGP), the cybersecurity software company specialising in digital identities, updated on trading for its financial year ended 31 March 2024.

Underlying trading has continued to show strong momentum with revenues for the year expected to be approximately 67% higher at £20m, which is in-line with forecasts.

The combination of higher revenues and the high operational gearing in the business is expected to result in improved profitability,…

Continue reading our content…

Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
  • Unlimited access to our market-beating portfolios
  • In-depth coverage of many of the world’s great companies
  • Unique insights from our top research team
Register FREE for access to limited content.
  • Company and markets insights
  • Sponsored content
  • Podcasts

Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Animalcare

BIG litigation | Big margins | Big dividends

30/09/2025 · Company Insights

News covered here includes our coverage of excellent results from a specialist medical device company, which…


Upgrades | Downgrades | Another takeover

24/07/2025 · Company Insights

Results and updates from AIM are coming think and fast. While the majority are positive, the…


More on Cake Box

Steady as ever | Decent value | Sweet returns

26/11/2025 · Company Insights

News covered here includes our review of positive results from an engineering services group and one…


Appealing dividends | US healthcare | Debt concerns

18/07/2025 · Company Insights

Hot on the heels of its first acquisition, a retailer of fresh cream cakes is chancing…


More on Impax Asset Management

Gold winner | Fishing delight | Veterinary vexation

08/10/2025 · Company Insights

The latest positive trading update from a beneficiary of the soaring gold price strangely saw the…


Appealing dividends | Excellent results | Trading ahead

11/07/2025 · Company Insights

News covered here includes our assessment of the latest results from AIM’s largest company. Despite being…


More on Intercede Group

Steady as ever | Decent value | Sweet returns

26/11/2025 · Company Insights

News covered here includes our review of positive results from an engineering services group and one…


Horror show | No deal | Bonkers Bargain delights

27/06/2025 · Company Insights

News covered here included our assessment of results from a provider of software to the public…


More on Microlise

Cracking results | Tough in ad world | Big contract woes

25/11/2025 · Company Insights

News covered here includes our assessment of excellent full year results from a provider of software…


Fast growers | Highly rated | Overseas winners

26/09/2025 · Company Insights

News and results covered here feature plenty of fast-growing UK companies, with many having notable success…


More on Surface Transforms

Survival of an innovator | Veterinary reassurance | Broker reluctance

24/07/2025 · Company Insights

A manufacturer of automative components sees its shares bounce as it gets to grips with production…


Will it survive? | Largest contract to date | Stunning results

12/06/2025 · Company Insights

News covered here includes our assessment of results from an innovative manufacturer, whose mere survival looks…


More on Warpaint London

Appealing dividends | Big director buying

12/09/2025 · Company Insights

News covered here incudes our assessment of encouraging interim results from Fevertree Drinks – one Director…


Big Buyback | Cosmetic growth | Back in tune?

29/04/2025 · Company Insights

News covered here includes our assessment of the latest trading update and share buyback from AIM’s…


More Company Insights

Steady as ever | Decent value | Sweet returns

Another share buyback | Not suited to public markets

20/11/2025 · Jet2 · Manolete Partners · MHA · PCI- PAL

More on Animalcare

BIG litigation | Big margins | Big dividends

Upgrades | Downgrades | Another takeover

Big Buyback | Cosmetic growth | Back in tune?

Dependable is downgraded | Enough fairy tales | Promising results

More on Cake Box

Steady as ever | Decent value | Sweet returns

Appealing dividends | US healthcare | Debt concerns

What’s the point!

Another AIM takeover | Bonkers Bargain delights | Profit warnings

More on Impax Asset Management

Gold winner | Fishing delight | Veterinary vexation

Appealing dividends | Excellent results | Trading ahead

Litigation issues | Modest valuation | Publishing doubts

Staggering dividends | Upgrades | Downgrades

More on Intercede Group

Steady as ever | Decent value | Sweet returns

Horror show | No deal | Bonkers Bargain delights

Bonkers Bargain climbs | Murray mayhem | Cancellation crash

Defence delights | Big dividends | Modest ratings

More on Microlise

Cracking results | Tough in ad world | Big contract woes

Fast growers | Highly rated | Overseas winners

Big share price move | Cyber impact | Wine wonders

Growth aplenty | Free cash flow focus | Low ball offer

More on Surface Transforms

Survival of an innovator | Veterinary reassurance | Broker reluctance

Will it survive? | Largest contract to date | Stunning results

AIM takeovers | Automotive excellence and struggles

Delightful results and special dividend | Bonkers Bargain impresses

More on Warpaint London

Appealing dividends | Big director buying

Big Buyback | Cosmetic growth | Back in tune?

Challenges in the US | Plenty to like

Cosmetic ambiguity | Public sector winner and loser

More Company Insights

Steady as ever | Decent value | Sweet returns
Cracking results | Tough in ad world | Big contract woes
Another share buyback | Not suited to public markets

Sign-up to our free email updates

SIGN UP